Evidence map›Paper›PMID 22205645›Full record

ArticleJournal of neurophysiology2012

Domain III regulates N-type (CaV2.2) calcium channel closing kinetics.

Viktor Yarotskyy, Guofeng Gao, Blaise Z Peterson, Keith S Elmslie

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. α-Neurexins Together with α2δ-1 Auxiliary Subunits Regulate CaThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  2. Article
  3. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Viktor YarotskyyDept. of Pharmacology, Kirksville Coll. of Osteopathic Medicine, AT Still Univ., 800 W. Jefferson St., Kirksville, MO 63501, USA.
Guofeng Gao
Blaise Z Peterson
Keith S Elmslie
A.T. Still University · USPenn State Milton S. Hershey Medical Center · US

Funding

Excitability of Afferents Evoking the Exercise Pressor ReflexR01AR059397 · NIAMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI ELMSLIE, KEITH S, KAUFMAN, MARC PETER · 2010 to 2019
$5.4M
Modulation of Ca Channels by Dihydropyridines and CaR01HL074143 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI PETERSON, BLAISE Z · 2005 to 2009
$1.7M
NHLBI NIH HHS HL-074143NHLBI NIH HHS R01 HL074143NIAMS NIH HHS AR-059397NIAMS NIH HHS R01 AR059397
6 · The paper itself

Abstract

Ca(V)2.2 (N-type) and Ca(V)1.2 (L-type) calcium channels gate differently in response to membrane depolarization, which is critical to the unique physiological functions mediated by these channels. We wondered if the source for these differences could be identified. As a first step, we examined the effect of domain exchange between N-type and L-type channels on activation-deactivation kinetics, which were significantly different between these channels. Kinetic analysis of chimeric channels revealed N-channel-like deactivation for all chimeric channels containing N-channel domain III, while activation appeared to be a more distributed function across domains. This led us to hypothesize that domain III was an important regulator of N-channel closing. This idea was further examined with R-roscovitine, which is a trisubstituted purine that slows N-channel deactivation by exclusively binding to activated N-channels. L-channels lack this response to roscovitine, which allowed us to use N-L chimeras to test the role of domain III in roscovitine modulation of N-channel deactivation. In support of our hypothesis, all chimeric channels containing the N-channel domain III responded to roscovitine with slowed deactivation, while those chimeric channels with L-channel domain III did not. Thus a combination of kinetic and pharmacological evidence supports the hypothesis that domain III is an important regulator of N-channel closing. Our results support specialization of gating functions among calcium channel domains.

Indexed as

AnimalsBiophysical PhenomenaCalcium Channels, N-TypeElectric StimulationHEK293 CellsHumansIon Channel GatingMembrane PotentialsMutant Chimeric ProteinsPatch-Clamp TechniquesProtein Kinase InhibitorsProtein Structure, TertiaryProtein SubunitsPurinesRabbitsRoscovitineCalcium Channels, N-TypeMutant Chimeric ProteinsProtein Kinase InhibitorsProtein SubunitsPurinesRoscovitine

Identifiers

PMID22205645
PMCPMC3331666
OpenAlexW1996098823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.